Clin Colon Rectal Surg 2017; 30(05): 333-338
DOI: 10.1055/s-0037-1606110
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Is There Any Reason Not to Perform Standard Laparoscopic Total Mesorectal Excision?

Zaher Lakkis
1   Department of Colorectal Surgery, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, University Denis-Diderot (Paris 7), Clichy, France
,
Yves Panis
1   Department of Colorectal Surgery, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, University Denis-Diderot (Paris 7), Clichy, France
› Author Affiliations
Further Information

Publication History

Publication Date:
27 November 2017 (online)

Abstract

The curative treatment of locally advanced rectal cancer is currently based on chemoradiotherapy and total mesorectal excision (TME). Laparoscopy has developed considerably because of obvious clinical benefits such as reduced pain and shorter hospital stay. Recently, several prospective randomized clinical trials with long-term follow-up have showed that laparoscopy is noninferior to laparotomy with the same oncologic outcomes in terms of survival and local control rate. However, laparoscopic TME remains a challenging procedure requiring a high level of expertise and a long learning curve to ensure an adequate and safe resection. The only relative contraindication of laparoscopic rectal surgery is T4 rectal cancer extended beyond the plane of TME. In this situation, it is reasonable to consider an open resection to avoid an uncomplete resection. In obese and elderly patients, laparoscopic TME also provides the same benefits as in nonobese and younger patients but may be more difficult to achieve. This review summarizes current knowledge on the place of laparoscopic TME in the treatment of rectal cancer.

 
  • References

  • 1 Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133 (08) 894-899
  • 2 Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1 (8496): 1479-1482
  • 3 Bosset JF, Collette L, Calais G. , et al; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355 (11) 1114-1123
  • 4 Kapiteijn E, Marijnen CA, Nagtegaal ID. , et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345 (09) 638-646
  • 5 van Gijn W, Marijnen CA, Nagtegaal ID. , et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12 (06) 575-582
  • 6 Buunen M, Veldkamp R, Hop WC. , et al; Colon Cancer Laparoscopic or Open Resection Study Group. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 2009; 10 (01) 44-52
  • 7 Maggiori L, Bretagnol F, Aslam MI. , et al. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?. Surgery 2014; 155 (03) 468-475
  • 8 Chau A, Maggiori L, Debove C, Kanso F, Hennequin C, Panis Y. Toward the end of abdominoperineal resection for rectal cancer? An 8-year experience in 189 consecutive patients with low rectal cancer. Ann Surg 2014; 260 (05) 801-805 , discussion 805–806
  • 9 van der Pas MH, Haglind E, Cuesta MA. , et al; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013; 14 (03) 210-218
  • 10 Debove C, Maggiori L, Chau A, Kanso F, Ferron M, Panis Y. What happens after R1 resection in patients undergoing laparoscopic total mesorectal excision for rectal cancer? A study in 333 consecutive patients. Colorectal Dis 2015; 17 (03) 197-204
  • 11 Bretagnol F, Panis Y, Rullier E. , et al; French Research Group of Rectal Cancer Surgery (GRECCAR). Rectal cancer surgery with or without bowel preparation: The French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 2010; 252 (05) 863-868
  • 12 Kanso F, Maggiori L, Debove C, Chau A, Ferron M, Panis Y. Perineal or abdominal approach first during intersphincteric resection for low rectal cancer: which is the best strategy?. Dis Colon Rectum 2015; 58 (07) 637-644
  • 13 Denost Q. GRECCAR 5. International trials results forum. ESCP 10th Scientific & Annual Meeting. Dublin; 2015
  • 14 Washington MK, Berlin J, Branton P. , et al; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 2009; 133 (10) 1539-1551
  • 15 Tuech JJ, Karoui M, Lelong B. , et al. A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 2015; 261 (02) 228-233
  • 16 Park EJ, Cho MS, Baek SJ. , et al. Long-term oncologic outcomes of robotic low anterior resection for rectal cancer: a comparative study with laparoscopic surgery. Ann Surg 2015; 261 (01) 129-137
  • 17 Hanna MH, Vinci A, Pigazzi A. Diverting ileostomy in colorectal surgery: when is it necessary?. Langenbecks Arch Surg 2015; 400 (02) 145-152
  • 18 Olagne E, Baulieux J, de la Roche E. , et al. Functional results of delayed coloanal anastomosis after preoperative radiotherapy for lower third rectal cancer. J Am Coll Surg 2000; 191 (06) 643-649
  • 19 Orcutt ST, Balentine CJ, Marshall CL. , et al. Use of a Pfannenstiel incision in minimally invasive colorectal cancer surgery is associated with a lower risk of wound complications. Tech Coloproctol 2012; 16 (02) 127-132
  • 20 Lacy AM, García-Valdecasas JC, Delgado S. , et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002; 359 (9325): 2224-2229
  • 21 Veldkamp R, Kuhry E, Hop WC. , et al; COlon cancer Laparoscopic or Open Resection Study Group (COLOR). Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005; 6 (07) 477-484
  • 22 Nelson H, Sargent DJ, Wieand HS. , et al; Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350 (20) 2050-2059
  • 23 Bonjer HJ, Hop WC, Nelson H. , et al; Transatlantic Laparoscopically Assisted vs Open Colectomy Trials Study Group. Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Arch Surg 2007; 142 (03) 298-303
  • 24 Panis Y, Maggiori L, Caranhac G, Bretagnol F, Vicaut E. Mortality after colorectal cancer surgery: a French survey of more than 84,000 patients. Ann Surg 2011; 254 (05) 738-743 , discussion 743–744
  • 25 Alnasser M, Schneider EB, Gearhart SL. , et al. National disparities in laparoscopic colorectal procedures for colon cancer. Surg Endosc 2014; 28 (01) 49-57
  • 26 Jeong SY, Park JW, Nam BH. , et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 2014; 15 (07) 767-774
  • 27 Kang SB, Park JW, Jeong SY. , et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010; 11 (07) 637-645
  • 28 Guillou PJ, Quirke P, Thorpe H. , et al; MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365 (9472): 1718-1726
  • 29 Bonjer HJ, Deijen CL, Abis GA. , et al; COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 2015; 372 (14) 1324-1332
  • 30 Andersson J, Abis G, Gellerstedt M. , et al. Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II). Br J Surg 2014; 101 (10) 1272-1279
  • 31 Andersson J, Angenete E, Gellerstedt M. , et al. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial. Br J Surg 2013; 100 (07) 941-949
  • 32 Arezzo A, Passera R, Salvai A. , et al. Laparoscopy for rectal cancer is oncologically adequate: a systematic review and meta-analysis of the literature. Surg Endosc 2015; 29 (02) 334-348
  • 33 Fleshman J, Branda M, Sargent DJ. , et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015; 314 (13) 1346-1355
  • 34 Stevenson AR, Solomon MJ, Lumley JW. , et al; ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015; 314 (13) 1356-1363
  • 35 Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y. T4 colorectal cancer: is laparoscopic resection contraindicated?. Colorectal Dis 2011; 13 (02) 138-143
  • 36 Debove C, Maggiori L, Chau A, Kanso F, Ferron M, Panis Y. Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: a study in 233 consecutive patients with mid or low rectal cancer. Int J Colorectal Dis 2015; 30 (02) 197-203
  • 37 Hrabe JE, Sherman SK, Charlton ME, Cromwell JW, Byrn JC. Effect of BMI on outcomes in proctectomy. Dis Colon Rectum 2014; 57 (05) 608-615
  • 38 Denost Q, Quintane L, Buscail E, Martenot M, Laurent C, Rullier E. Short- and long-term impact of body mass index on laparoscopic rectal cancer surgery. Colorectal Dis 2013; 15 (04) 463-469
  • 39 Bège T, Lelong B, Francon D, Turrini O, Guiramand J, Delpero JR. Impact of obesity on short-term results of laparoscopic rectal cancer resection. Surg Endosc 2009; 23 (07) 1460-1464
  • 40 Kamoun S, Alves A, Bretagnol F, Lefevre JH, Valleur P, Panis Y. Outcomes of laparoscopic colorectal surgery in obese and nonobese patients: a case-matched study of 180 patients. Am J Surg 2009; 198 (03) 450-455
  • 41 Qiu Y, Liu Q, Chen G. , et al. Outcome of rectal cancer surgery in obese and nonobese patients: a meta-analysis. World J Surg Oncol 2016; 14 (01) 23
  • 42 Karahasanoglu T, Hamzaoglu I, Baca B, Aytac E, Kirbiyik E. Impact of increased body mass index on laparoscopic surgery for rectal cancer. Eur Surg Res 2011; 46 (02) 87-93
  • 43 Oyasiji T, Baldwin K, Katz SC, Espat NJ, Somasundar P. Feasibility of purely laparoscopic resection of locally advanced rectal cancer in obese patients. World J Surg Oncol 2012; 10: 147
  • 44 Vargas GM, Sieloff EP, Parmar AD, Tamirisa NP, Mehta HB, Riall TS. Laparoscopy decreases complications for obese patients undergoing elective rectal surgery. Surg Endosc 2016; 30 (05) 1826-1832
  • 45 Chautard J, Alves A, Zalinski S, Bretagnol F, Valleur P, Panis Y. Laparoscopic colorectal surgery in elderly patients: a matched case-control study in 178 patients. J Am Coll Surg 2008; 206 (02) 255-260
  • 46 Frasson M, Braga M, Vignali A, Zuliani W, Di Carlo V. Benefits of laparoscopic colorectal resection are more pronounced in elderly patients. Dis Colon Rectum 2008; 51 (03) 296-300
  • 47 Zeng WG, Zhou ZX, Hou HR. , et al. Outcome of laparoscopic versus open resection for rectal cancer in elderly patients. J Surg Res 2015; 193 (02) 613-618
  • 48 Landi F, Vallribera F, Rivera JP, Bertoli P, Armengol M, Espin E. Morbidity after laparoscopic and open rectal cancer surgery: a comparative analysis of morbidity in octogenarians and younger patients. Colorectal Dis 2016; 18 (05) 459-467
  • 49 Kang CY, Halabi WJ, Chaudhry OO. , et al. A nationwide analysis of laparoscopy in high-risk colorectal surgery patients. J Gastrointest Surg 2013; 17 (02) 382-391